Elevated suppression of tumorigenicity 2 receptor is associated with poor outcome in heart failure with preserved ejection fraction - 26/03/18
Résumé |
Background |
Soluble suppression of tumorigenicity 2(sST2) receptor is a well-known biomarker implicated in inflammatory diseases. It has already been shown that sST2 is associated with worse outcome in HFrEF.
Objective |
We sought to evaluate the association of sST2 with clinical, laboratory and imaging findings and its prognostic value in HFpEF.
Methods |
Between January 2015 and June 2017, we prospectively enrolled 137 consecutive HFpEF patients (79±8 years, 61% women). Elevated sST2 was determined by an age and sex-adjusted cutoff value (55ng/ml) corresponding to mean+2 SD in 31 controls (75±6years, 61% women). All patients underwent complete 2D echo and cMR and were followed up for a composite outcome of mortality and first HF hospitalization.
Results |
Median sST2 level was 44.5ng/ml (IQR: 31.6–62.2ng/ml). Elevated sST2 patients (n=46) had an impaired right ventricular (RV) function (FAC 39±10% vs. 43±8%, P=0.017; RVEF by cMR 53.5±9.8% vs. 58.1±7.8%, P=0.008) and a higher proportion with pathologic RV/RA gradient (n=20 (40%) vs. n=23 (26%), P=0.034). They were similar for other clinical, laboratory and imaging characteristics. Multivariate logistic analysis showed that only RVEF by cMR was associated with high sST2 level (OR: 0.94 [0.89–0.99], P=0.010).
During a mean follow-up of 20±8months, 71 patients (52%) reached the combined end point. Cox analysis identified GFR, hemoglobin, sST2, use of loop diuretic and E/e’ ratio as significant predictors of outcome. Only GFR (HR=0.98 [0.96–0.99], P<0.001) and sST2 (HR=3.64 [1.37–9.65], P=0.009) were significantly associated with the composite outcome even after adjusting for important clinical and imaging covariables.
Kaplan Meier event free survival curve showed that high sST2 HFpEF patients had poorer prognosis than low sST2 patients (P=0.001, Fig. 1).
Conclusions |
In HFpEF, sST2 is associated with impaired RV function and with a poorer prognosis with higher rate of mortality and first HF hospitalization.
Le texte complet de cet article est disponible en PDF.Plan
Vol 10 - N° 2
P. 197 - avril 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?